SCHEMBL7737719

SCHEMBL7737719

NC(Cc1ccccc1)C(=O)OCc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.55
▸ ITGA4 P13612 1/20 0.54
▸ ITGB7 P26010 1/20 0.54
▸ NPC1 O15118 2/20 0.53
▸ MMP2 P08253 1/20 0.53
▸ MC4R P32245 1/20 0.53
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ IDO1 P14902 1/20 0.49
▸ CTSL P07711 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ ANPEP P15144 1/20 0.48
▸ ERAP2 Q6P179 1/20 0.48
▸ ERAP1 Q9NZ08 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ SLC15A1 P46059 1/20 0.48
▸ LTA4H P09960 1/20 0.48
▸ LAP3 P28838 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559285 0.90 MMP2 (0.56) RAB9AITGA4ITGB7MMP2IDO1
SCHEMBL6559288 0.90 MMP2 (0.56) RAB9AITGA4ITGB7MMP2IDO1
Phenylmethanesulfonic Acid SCHEMBL10341839 0.88 ITGA4 (0.49) RAB9AITGA4ITGB7NPC1MMP2
SCHEMBL10501021 0.87 ITGA4 (0.46) RAB9AITGA4ITGB7NPC1MMP2
SCHEMBL6897867 0.87 ITGA4 (0.46) RAB9AITGA4ITGB7NPC1MMP2
SCHEMBL10500994 0.87 ITGA4 (0.46) RAB9AITGA4ITGB7NPC1MMP2
SCHEMBL6076979 0.87 RAB9A (0.53) RAB9ANPC1MEN1KMT2ACTSL
SCHEMBL6076971 0.87 RAB9A (0.53) RAB9ANPC1MEN1KMT2ACTSL
SCHEMBL7063442 0.86 RAB9A (0.50) RAB9AITGA4ITGB7MEN1KMT2A
SCHEMBL6921335 0.86 GAA (0.57) RAB9AKMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 — — EP claimed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 — — WO claimed
US-6329394-B1 5HT3 ANTAGONIST AND NK1 RECEPTORS SUBSTANCE P ANTAGONISTS AND OTHER NEUROKININ ANTAGONISTS, IN THE TREATMENT OF EMESIS. GLAXO GROUP LIMITED (GB) 2001-12-11 — — US disclosed
EP-0819005-A4 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2001-03-21 — — EP disclosed
EP-0819005-A1 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1998-01-21 — — EP disclosed
US-5565568-A USEFUL IN TREATMENT OR PREVENTION OF A PHYSIOLOGICAL DISORDER ASSOCIATED WITH AN EXCESS OF TACHYKININS ELI LILLY AND COMPANY (US) 1996-10-15 — — US disclosed
WO-1996031214-A1 2-ACYLAMINOPROPANAMIDES AS TACHYKININ RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-10-10 — — WO disclosed
US-5547964-A ANTIEMETIC DURING DRUG THERAPY GLAXO GROUP LIMITED (GB) 1996-08-20 — — US disclosed
US-5472978-A Tachykinin antagonists for treating pain, migraine and antiinflammatory agents MERCK SHARP & DOHME LTD. (GB) 1995-12-05 — — US disclosed
EP-0615751-A1 Use of tachykinin antagonists in the treatment of emesis GLAXO GROUP LIMITED (GB) 1994-09-21 — — EP disclosed
EP-0593559-A1 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LTD. (GB) 1994-04-27 — — EP disclosed
WO-1993001169-A2 AROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-01-21 — — WO disclosed
Send feedback